142 related articles for article (PubMed ID: 24815455)
1. Influence of mammographic screening on breast cancer incidence trends in South Australia.
Beckmann KR; Roder DM; Hiller JE; Farshid G; Lynch JW
Asian Pac J Cancer Prev; 2014; 15(7):3105-12. PubMed ID: 24815455
[TBL] [Abstract][Full Text] [Related]
2. Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.
Jacklyn G; McGeechan K; Irwig L; Houssami N; Morrell S; Bell K; Barratt A
Breast Cancer Res Treat; 2017 Dec; 166(3):843-854. PubMed ID: 28822001
[TBL] [Abstract][Full Text] [Related]
3. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia.
Wilson LF; Page AN; Dunn NA; Pandeya N; Protani MM; Taylor RJ
Maturitas; 2013 Dec; 76(4):370-6. PubMed ID: 24113278
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer mortality trends in Australia: 1921 to 1994.
Smith CL; Kricker A; Armstrong BK
Med J Aust; 1998 Jan; 168(1):11-4. PubMed ID: 9451388
[TBL] [Abstract][Full Text] [Related]
5. Disentangling the roles of mammographic screening and HRT in recent breast cancer incidence trends in italy by analyses based on calendar time and time since screening activation.
Crocetti E; Buzzoni C; Falcini F; Cortesi L; De Lisi V; Ferretti S; Tumino R; Russo A; Paci E
Breast J; 2010; 16(4):350-5. PubMed ID: 20443789
[TBL] [Abstract][Full Text] [Related]
6. Trends in mammography, hormone replacement therapy, and breast cancer incidence and mortality in Canadian women.
Zakaria D; Shaw A
Cancer Causes Control; 2019 Feb; 30(2):137-147. PubMed ID: 30637599
[TBL] [Abstract][Full Text] [Related]
7. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Breast Cancer Mortality Trends Associated With Mammographic Screening and Adjuvant Therapy From 1986 to 2013 in the State of Victoria, Australia.
Burton R; Stevenson C
JAMA Netw Open; 2020 Jun; 3(6):e208249. PubMed ID: 32573707
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk factors in Queensland women attending population-based mammography screening.
Protani M; Page A; Taylor R; Glazebrook R; Lahmann PH; Branch E; Muller J
Maturitas; 2012 Mar; 71(3):279-86. PubMed ID: 22225652
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991.
Burton RC; Bell RJ; Thiagarajah G; Stevenson C
Breast Cancer Res Treat; 2012 Feb; 131(3):949-55. PubMed ID: 21956213
[TBL] [Abstract][Full Text] [Related]
11. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006.
Séradour B; Allemand H; Weill A; Ricordeau P
Bull Cancer; 2009 Apr; 96(4):E1-6. PubMed ID: 19435691
[TBL] [Abstract][Full Text] [Related]
12. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study.
Morrell S; Taylor R; Roder D; Dobson A
J Med Screen; 2012 Mar; 19(1):26-34. PubMed ID: 22345322
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
14. Impact of hormone replacement therapy use on mammographic screening outcomes.
Beckmann KR; Farshid G; Roder DM; Hiller JE; Lynch JW
Cancer Causes Control; 2013 Jul; 24(7):1417-26. PubMed ID: 23649232
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening?
Hofvind S; Sakshaug S; Ursin G; Graff-Iversen S
Int J Cancer; 2012 Jun; 130(12):2930-8. PubMed ID: 21732346
[TBL] [Abstract][Full Text] [Related]
16. Do breast cancer risk factors differ among those who do and do not undertake mammography screening?
Beckmann KR; Roder DM; Hiller JE; Farshid G; Lynch JW
J Med Screen; 2013 Dec; 20(4):208-19. PubMed ID: 24153439
[TBL] [Abstract][Full Text] [Related]
17. A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening.
Beckmann KR; Lynch JW; Hiller JE; Farshid G; Houssami N; Duffy SW; Roder DM
Int J Cancer; 2015 Mar; 136(6):1411-21. PubMed ID: 25098753
[TBL] [Abstract][Full Text] [Related]
18. Recent trends in U.S. breast cancer incidence, survival, and mortality rates.
Chu KC; Tarone RE; Kessler LG; Ries LA; Hankey BF; Miller BA; Edwards BK
J Natl Cancer Inst; 1996 Nov; 88(21):1571-9. PubMed ID: 8901855
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer incidence in Spain before, during and after the implementation of screening programmes.
Pollán M; Michelena MJ; Ardanaz E; Izquierdo A; Sánchez-Pérez MJ; Torrella A;
Ann Oncol; 2010 May; 21 Suppl 3():iii97-102. PubMed ID: 20427367
[TBL] [Abstract][Full Text] [Related]
20. History of screening by BreastScreen New South Wales of women with invasive breast cancer.
Li M; Warner-Smith M; McGill S; Roder D; Currow D
Cancer Epidemiol; 2020 Feb; 64():101659. PubMed ID: 31855779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
